FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

17031711000001102: Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-May 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
59457101000001117 Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
59457201000001112 Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Is a Co-proxamol 32.5mg/325mg tablets true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Is a Co-proxamol 32.5mg/325mg tablets false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Is a Product containing precisely dextropropoxyphene 32.5 milligram and paracetamol 325 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has specific active ingredient Dextropropoxyphene hydrochloride true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has specific active ingredient Paracetamol true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) 100 tablet 10 x 10 tablets Has AMP True Co-proxamol 32.5mg/325mg tablets (Lexon (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start